180+ networks across 21 NJ counties
COMMUNITY ENGAGEMENT CORE OVERVIEW
NJACTS draws leading academic, industry and community groups together to understand and address the health needs of New Jersey. Central to this is engagement with our community to ensure that our efforts respond to their priorities. Our goal is to conduct research with the New Jersey community, in the community and for the community, and yet, have impact beyond our state’s boundaries.
Stay in Touch!
Join RCommunity!
Join Rutgers Health Service Corps!
Empowering Community-Based Research
Through Cultural and Linguistic Collaboration
- Navigating interpreter-mediated encounters
- Effective translation for research
- Understanding cultural nuances in literacy, trust, and belonging
Through collaboration across disciplines and leveraging expertise within and beyond Rutgers, CrEER ensures that research is culturally relevant and impactful both locally and globally.
👉 Discover how CrEER is shaping the future of community-based research here.
Association for Clinical and Translational Science (ATCS) Membership for Community Members
Did you know that community members are eligible to become members of ACTS through their affiliation with NJ ACTS?
Community members are able to access ACTS’ member benefits, including:
- Discounted registration to the annual Translational Science meeting
- Opportunities to participate in Special Interest Groups and Committees
- Access to the community platform website and more!
Resource for Investigators – CTSA Compendium of D&I Catalogs
Dissemination and implementation (D&I) research focuses on translating evidence-based interventions into real-world settings to improve health outcomes in the broader community.
An open-source CTSA Compendium of D&I Catalogs has been developed by the Clinical & Translational Science Awards (CTSA) Program’s “Advancing Dissemination and Implementation Sciences in CTSAs” working group to support investigators at any stage of their D&I skill-building journey. It provides a curated list of resource catalogs relevant to the conduct of D&I science. The materials include frameworks/theories/models, methods/measures, funding resources, and practice and training resources.
Click here to learn more.
CIRTification – A New Alternative to CITI for Community Partners
The rollout of CIRTification at Rutgers has begun. The CIRTification program provides research ethics training alternatives for individuals in community organizations, with limited understanding of conducting human research and protecting potential research participants. This option provides training focused on equipping community partners to conduct human subject research effectively and safely in their communities.
To learn more about the program at Rutgers, please visit this link CIRTification.
NJ ACTS COMMUNITY SCIENTIST PROGRAM
This program is designed to provide researchers with rapid feedback from expert community members to ensure their research projects are culturally appropriate and relevant to the community.
PARTICIPATE IN OUR NEXT COHORT!
For more information, please contact njactscommunity@rwjms.rutgers.edu
NJ HEROES TOO
Through the ongoing New Jersey Healthcare Essential Worker Outreach and Education Study – Testing Overlooked Occupations (NJ HEROES TOO), we have gained a wealth of data on COVID-19’s effects, gleaned valuable learnings on attitudes toward testing and vaccines, and improved COVID-19 awareness in underserved communities.
Community Blog
Murphy says coronavirus vaccines are coming soon. But distribution may be tough, experts say
New Jersey can expect the “first batch" of a coronavirus vaccine "maybe by the end of the year,” Gov. Phil Murphy said at his Monday briefing, adding that the timing of widespread distribution will depend on the availability of the vaccines and the distribution...
Rutgers-Eagleton Poll: About Four in 10 New Jerseyans Say They Won’t Get COVID-19 Vaccine
Between 36 percent and 47 percent of New Jerseyans say they will “probably” or “definitely” not get vaccinated against COVID-19, with response rates varying depending on how the question is asked, according to the latest Rutgers-Eagleton Poll. Among individuals...
Pfizer COVID-19 Vaccine Gets Approval from Key FDA Panel
An independent advisory committee for the Food and Drug Administration voted Thursday to recommendTrusted Source emergency approval of a COVID-19 vaccine developed by Pfizer and BioNTech. The FDA isn’t required to follow the advice of the Vaccines and Related...
President-elect Biden, you need a nurse on your Covid task force
President-elect Joe Biden announced his Covid-19 Transition Advisory Board, a 13-person group of distinguished public health experts, physicians, academics, and commissioners. Biden stated that the team will assist in translating his Covid-19 plan into action,...
How Will Consumers Shop During the Holidays This Year?
With holiday shopping in full swing, retail and consumer behavior will look different due to the coronavirus pandemic. But how will local and big box retailers be impacted and what will the shopping experience look like for the everyday consumer? Rutgers Today spoke...
Now Pfizer and BioNTech Say Their COVID-19 Vaccine Candidate Is 95% Effective
Last week, Pfizer and BioNTech said their experimental COVID-19 vaccine was 90% effective in early interim results. And yesterday, they announced that their mRNA-based vaccine candidate is 95% effective at preventing COVID-19. Dr. Reynold Panettieri Jr. of Robert Wood...